Clinical Trial Details


Research Study Summary

Have you been diagnosed with Gastroesophageal Reflux Disease (GERD)?


Steven Duckor MD, FACG of Advanced Clinical Research Institute is seeking participants for a clinical research study. The purpose of the study is to evaluate the effects of an investigational inhaled drug that is being tested for the treatment of symptomatic Gastroesophageal Reflux Disease (GERD)?

Inclusion Criteria:

  • Do you suffer from Heartburn at least 3 days per week?
  • Do you suffer from Regurgitation at least 3 days per week?
  • Have you been diagnosed with Gastroesophageal Reflux Disease (GERD)?

If you answered yes to the previous questions, and you are between the ages of 18-70 years old, you may qualify to participate. Participation in this study will include:

  • A physical exam
  • A diagnostic upper gastrointestinal endoscopy procedure
  • Laboratory tests
  • Electrocardiogram

Without any cost to you or your health insurance. You may be compensated for your participation.

For more information visit

To Learn more

CW ID: 61244
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Both Male and Female
18 to 70 Years
Overall Status
Facility Type


For more information visit

Lupe Castro
Anaheim Clinical Trials (ACT)
2617 East Chapman Avenue
Suite 302
Orange, CA 92689
Phone: 714-633-1823 Ext. 232
Fax: 714-532-4891

View Map

Research Center Information:

Anaheim Clinical Trials (ACT)

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.